Experimental group:AYK103 injection

2 trials

Sponsors

Shanghai Sixth People‘s Hospital, Huhhot Second Hospital

Conditions

CancerLiver Cancer

Early Phase 1

IIT Study on the Safety and Tolerance of AYK103 Injection in Advanced Solid Tumor

Active, not recruitingChiCTR2300070786

Shanghai Sixth People‘s HospitalCancer

Start: 2023-05-01Updated: 2023-06-04

IIT study on the efficacy and safety of minimally invasive ablation combined with AYK103 injection in the treatment of liver cancer

RecruitingChiCTR2300073451

Huhhot Second HospitalLiver Cancer

Start: 2023-07-05Updated: 2023-07-16